Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959307 · ClinicalTrials.gov registry record · NA
Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02959307: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02959307 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02959307, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Transcranial Light Therapy involves non-invasive and invisible beams of light that increase energy metabolism in the brain. Transcranial light therapy has been found to promote brain metabolism which may help people with depression. The research team proposes a novel approach to treating depression by using transcranial light therapy.
Interventions
- DEVICE Transcranial Light Therapy
- DEVICE Sham Transcranial Light Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02959307
The ClinicalTrials.gov registry entry for NCT02959307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Light Therapy is the first listed.
NCT02959307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02959307 about?
NCT02959307 is a clinical study titled "Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)". Transcranial Light Therapy involves non-invasive and invisible beams of light that increase energy metabolism in the brain. Transcranial light therapy has been found to promote brain metabolism which may help people with depression. The research team proposes a novel approach to treating depression ...
What is the current status of trial NCT02959307?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2016-11. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02959307?
The interventions under investigation include: Transcranial Light Therapy (DEVICE), Sham Transcranial Light Therapy (DEVICE).
Who is sponsoring clinical trial NCT02959307?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.